Skip to content
Open access · CC-BY via OpenAlex

Incidence of Alzheimer’s Disease in Men with Late-Life Hypertension Is Ameliorated by FOXO3 Longevity Genotype

Randi Chen, Brian J. Morris, Timothy A. Donlon, George Webster Ross, Kalpana J. Kallianpur, Richard Allsopp, Kazuma Nakagawa, Bradley J. Willcox, Kamal Masaki

Journal of Alzheimer s Disease · 2023 · ▲ 9 citations

Abstract

BACKGROUND: It is well established that mid-life hypertension increases risk of dementia, whereas the association of late-life hypertension with dementia is unclear. OBJECTIVE: To determine whether FOXO3 longevity-associated genotype influences the association between late-life hypertension and incident dementia. METHODS: Subjects were 2,688 American men of Japanese ancestry (baseline age: 77.0±4.1 years, range 71-93 years) from the Kuakini Honolulu Heart Program. Status was known for FOXO3 rs2802292 genotype, hypertension, and diagnosis of incident dementia to 2012. Association of FOXO3 genotype with late-life hypertension and incident dementia, vascular dementia (VaD) and Alzheimer's disease (AD) was assessed using Cox proportional hazards models. RESULTS: During 21 years of follow-up, 725 men were diagnosed with all-cause dementia, 513 with AD, and 104 with VaD. A multivariable Cox model, adjusting for age, education, APOEɛ4, and cardiovascular risk factors, showed late-life hypertension increased VaD risk only (HR = 1.71, 95% CI = 1.08-2.71, p = 0.022). We found no significant protective effect of FOXO3 longevity genotype on any type of dementia at the population level. However, in a full Cox model adjusting for age, education, APOEɛ4, and other cardiovascular risk factors, there was a significant interaction effect of late-life hypertension and FOXO3 longevity genotype on incident AD (β= -0.52, p = 0.0061). In men with FOXO3 rs2802292 longevity genotype (TG/GG), late-life hypertension showed protection against AD (HR = 0.72; 95% CI = 0.55-0.95, p = 0.021). The non-longevity genotype (TT) (HR = 1.16; 95% CI = 0.90-1.51, p = 0.25) had no protective effect. CONCLUSION: This longitudinal study found late-life hypertension was associated with lower incident AD in subjects with FOXO3 genotype.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3233/jad-230350
Canonical
link ↗
Fetched
2026-10-23 MST

Cite this

APA
Chen, R., Morris, B.J., Donlon, T.A., Ross, G.W., Kallianpur, K.J., Allsopp, R., Nakagawa, K., Willcox, B.J., &amp; Masaki, K. (2023). Incidence of Alzheimer’s Disease in Men with Late-Life Hypertension Is Ameliorated by FOXO3 Longevity Genotype. <em>Journal of Alzheimer s Disease</em>. https://doi.org/10.3233/jad-230350
Vancouver
Chen R, Morris BJ, Donlon TA, Ross GW, Kallianpur KJ, Allsopp R, et al. Incidence of Alzheimer’s Disease in Men with Late-Life Hypertension Is Ameliorated by FOXO3 Longevity Genotype. Journal of Alzheimer s Disease. 2023. doi:10.3233/jad-230350.
BibTeX
@article{randi2023Incide, title = {Incidence of Alzheimer’s Disease in Men with Late-Life Hypertension Is Ameliorated by FOXO3 Longevity Genotype}, author = {Randi Chen and Brian J. Morris and Timothy A. Donlon and George Webster Ross and Kalpana J. Kallianpur and Richard Allsopp and Kazuma Nakagawa and Bradley J. Willcox and Kamal Masaki}, journal = {Journal of Alzheimer s Disease}, year = {2023}, doi = {10.3233/jad-230350}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings